SCHEMBL5564381

SCHEMBL5564381

CCOC(COCOc1cccc([N+](=O)[O-])c1)OCC

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 2/20 0.50
CHRNA4 P43681 2/20 0.50
ATM Q13315 1/20 0.49
FFAR1 O14842 1/20 0.45
NPC1 O15118 1/20 0.45
KEAP1 Q14145 1/20 0.44
NFE2L2 Q16236 1/20 0.44
CHRNB4 P30926 1/20 0.44
CHRNA3 P32297 1/20 0.44
GRM5 P41594 1/20 0.42
MAOB P27338 1/20 0.42
LTA4H P09960 1/20 0.40
PTGS2 P35354 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1008449 0.85 CHRNB2 (0.58) CHRNB2CHRNA4KEAP1NFE2L2CHRNB4
SCHEMBL4701140 0.79 CHRNB2 (0.61) CHRNB2CHRNA4CHRNB4CHRNA3GRM5
SCHEMBL1985000 0.79 CHRNB2 (0.65) CHRNB2CHRNA4KEAP1NFE2L2CHRNB4
SCHEMBL31037156 0.79 CHRNB2 (0.65) CHRNB2CHRNA4KEAP1NFE2L2CHRNB4
SCHEMBL16178929 0.79 CHRNB2 (0.64) CHRNB2CHRNA4CHRNB4CHRNA3GRM5
SCHEMBL5149611 0.78 CHRNB2 (0.57) CHRNB2CHRNA4CHRNB4CHRNA3GRM5
Ammonia Solution, Strong SCHEMBL3031537 0.77 CHRNB2 (0.63) CHRNB2CHRNA4NPC1KEAP1NFE2L2
Hydrochloric Acid SCHEMBL10551173 0.77 CHRNB2 (0.62) CHRNB2CHRNA4CHRNB4CHRNA3GRM5
Hydrochloric Acid SCHEMBL10551171 0.77 CHRNB2 (0.62) CHRNB2CHRNA4CHRNB4CHRNA3GRM5
Hydrochloric Acid SCHEMBL10551164 0.77 CHRNB2 (0.62) CHRNB2CHRNA4CHRNB4CHRNA3GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1773808-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION THEREOF AND PHARMACEUTICAL USE THEREOF AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2007-04-18 EP disclosed
WO-2006010641-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION THEREOF AND PHARMACEUTICAL USE THEREOF AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2006-02-02 WO disclosed